EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies

Omar Badla iD, Beshr Abdulaziz Badla iD, Amr Almobayed iD, Carlos Mendoza iD, Krishna Kishor, Sanjoy K Bhattacharya

Pharmaceuticals · 27.09.2024 · 17 (10) · 1281

DOI: 10.3390/ph17101281 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.09.2024. Verfasst von Omar Badla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School Medicine, Miami, FL 33136, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of arteritic anterior ischemic optic neuropathy (AAION), non-arteritic ischemic optic neuropathy (NAAION), and posterior ischemic optic neuropathy (PION) is a topic of ongoing research with mixed evidence on some pharmacotherapies and a need for more consensus. This manuscript provides an overview of these conditions’ current, potential future, and attempted pharmacotherapies. AAION’s current treatment regimen consists of high-dose steroids, with methotrexate, tocilizumab, and abatacept, being the most viable steroid-sparing therapy candidates. As for NAAION, the treatments being tried are vast, with mixed evidence supporting each modality. Similarly, despite the various treatment options explored, there still needs to be a universally effective therapy for PION. More research is needed to formulate an agreed-upon treatment regimen for these conditions.

Schlagwörter

Stichwörter der Autor:innen

AAIONAIONIONNAAIONNAIONPIONischemic optic neuropathymanagementpharmacotherapy

Autor:innen und Institutionen

  • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School Medicine, Miami, FL 33136, USA.
  • Miami Integrative Metabolomics Research Center, Miami, FL 33136, USA.
  • College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
  • Graduate Program in Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

ORCID-Profile: Omar Badla, Beshr Abdulaziz Badla, Amr Almobayed, Carlos Mendoza

Zitieren

APA

Badla, O., Badla, B. A., Almobayed, A., Mendoza, C., Kishor, K., & Bhattacharya, S. K. (2024). Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies. Pharmaceuticals, 17(10), 1281. https://doi.org/10.3390/ph17101281

Vancouver

Badla O, Badla BA, Almobayed A, Mendoza C, Kishor K, Bhattacharya SK. Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies. Pharmaceuticals. 2024;17(10):1281. doi:10.3390/ph17101281

BibTeX
@article{Badla2024,
  author = {Badla, Omar and Badla, Beshr Abdulaziz and Almobayed, Amr and Mendoza, Carlos and Kishor, Krishna and Bhattacharya, Sanjoy K},
  title = {Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {10},
  pages = {1281},
  doi = {10.3390/ph17101281}
}
Kostenlos starten →